OpenAI Launches GPT-Rosalind for Biology and Drug Discovery
OpenAI has introduced GPT-Rosalind, a specialized AI model for life sciences research. The system aims to accelerate drug discovery and biological analysis workflows.
OpenAI has introduced GPT-Rosalind, a specialized AI model for life sciences research. The system aims to accelerate drug discovery and biological analysis workflows.
Amazon has launched Health AI, an agentic assistant on its website and app that helps users understand medical records, manage prescriptions, and connect with doctors. Prime members will receive limited free virtual care consultations.
Henry Schein One has partnered with Amazon Web Services to integrate generative AI across its dental software platforms, aiming to modernize clinical workflows and patient care.